Late‐midlife lifestyle and brain and cognitive changes in individuals on the AD versus non‐AD continuum
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring,
Journal Year:
2025,
Volume and Issue:
17(2)
Published: April 1, 2025
Abstract
INTRODUCTION
We
investigated
whether
a
composite
measure
of
late‐midlife
lifestyle
was
associated
with
(1)
longitudinal
brain
changes
and
(2)
cognitive
when
adjusting
for
these
changes.
METHODS
used
linear
mixed
models
to
examine
the
LIfestyle
BRAin
Health
(LIBRA)
index
in
tau,
white
matter
hyperintensity,
neurodegeneration,
cognition
were
similar
amyloid
positive
(A+;
>
17
Centiloids)
negative
participants.
RESULTS
included
324
individuals
from
Wisconsin
Registry
Alzheimer's
Prevention
(39%
apolipoprotein
E
[
APOE
]
4
carrier,
30%
A+,
prior
baseline
age
67
[50–75]).
The
LIBRA
not
biomarker
trajectories
or
primary
outcome
trajectory.
There
inconsistent
effects
on
secondary
domain‐specific
trajectories.
In
contrast,
tau
neurodegeneration
strongly
DISCUSSION
age‐range
disease‐range
studied,
did
exhibit
meaningful
effect
disease
vascular
accumulation
consistently
Highlights
this
age‐range,
Effects
lifestyle,
if
any,
may
take
more
time
manifest.
Language: Английский
Distinct gut microbiota profiles may characterize amyloid beta pathology and mild cognitive impairment
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 3, 2024
Abstract
Gut
microbiome
composition
has
been
associated
with
early
preclinical
Alzheimer’s
disease
(AD),
as
reflected
by
cerebrospinal
fluid
(CSF)
amyloid
beta
pathology,
and
mild
cognitive
impairment
(MCI).
However,
the
presence
of
distinct
microbiota
across
different
stages
not
fully
characterized.
We
profiled
gut
in
50
nondemented
individuals
16S
ribosomal
RNA
sequencing
taxonomic
profiles
were
compared
between
amyloid-based
(amyloid-normal
vs.
amyloid-pathology)
clinically-
based
(cognitively
normal
MCI)
diagnosis
groups
using
linear
models
(adjusted
for
sex,
age
diet).
Elastic
net
regression
model
was
used
to
assess
discriminative
performance
amyloid-pathology
MCI.
Microbial
diversity
measures
did
differ
groups.
identified
specific
genera
MCI
such
Oxalobacter,
Marvinbryantia
Escherichia-Shigella
,
mostly
linked
inflammation.
Distinct
found
be
unique
Microbiota
shown
have
a
fairly
good
performance.
Overall,
we
suggest
stage
AD
MCI,
which
needs
further
explored.
Language: Английский
High-Risk Factors for Brain Aging
Published: April 26, 2024
The
overall
health
of
the
US
population
has
been
improving
for
last
100
years.
People
are
living
longer
although
healthcare
disparities
continue.
By
2050,
number
adults
over
40
with
dementia
is
projected
to
increase
from
5.2
million
people
10.5
million,
according
Lancet
published
in
January
2022.
will
be
nearly
tripling
globally.
Dementia
an
escalated
cost
healthcare,
social
welfare
and
emotional
financial
burdens
caregivers.
Language: Английский